+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06676553

A Randomized Trial Comparing Guided Versus Conventional Renal Denervation Using Renal Artery Stimulation to Improve Blood Pressure in Adults with Hypertension

Led by National Taiwan University Hospital · Updated on 2024-11-06

32

Participants Needed

1

Research Sites

86 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate two methods of renal denervation in patients with hypertension, focusing on whether using intraprocedural feedback from renal artery stimulation can improve outcomes compared to the conventional approach. It builds on earlier findings that persistent blood pressure increases triggered by renal artery stimulation after the initial procedure indicate poorer blood pressure control six months later. The trial specifically compares a guided strategy that includes additional ablations based on immediate feedback to a standard approach without repeat procedures. Participants receive sedation with intravenous propofol during the procedure. Renal artery stimulation is performed at two sites in both renal arteries to measure systolic blood pressure response and artery constriction. Renal denervation is done with a multielectrode catheter applying radiofrequency ablations. After the initial denervation, stimulation is repeated to assess blood pressure changes. In the guided strategy group, further ablations target arteries where stimulation still causes a systolic blood pressure rise of 20 mmHg or more in the conventional group, no additional denervation is performed. During the study, participants are monitored for blood pressure changes over 24 hours at six months post-procedure, which is the main outcome. Secondary measures include changes in diastolic blood pressure, awake and asleep heart rate and blood pressure, and kidney function tests. Blood pressure readings are carefully averaged to reduce fluctuations, and body reactions during stimulation are recorded. The study runs from October 2024 to June 2028, with randomized assignment and triple masking to ensure objective results.

CONDITIONS

Brief Title

INtraprocedural Feedback-Optimized Renal Denervation Based on Measurements Obtained Through Renal Artery Stimulation: a Randomized Controlled Trial (INFORM)

Research Team

T

Tzung-Dau Wang, MD, PhD

Y

Ya-Chun Chen, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here